Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Status:
Withdrawn
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that DCCR is effective as both monotherapy and in combination
with a statin in lowering triglycerides in subjects with very high triglycerides